Lido Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Lido Advisors's RPRX Position: Q2 2026 in Review
Lido Advisors increased its Royalty Pharma (RPRX) stake by 31% in Q2 2026, buying an estimated $307K and bringing the position to 25,158 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #940.
Lido Advisors first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Lido Advisors held 25,158 shares of Royalty Pharma worth $1.41M as of Q2 2026.
- Lido Advisors bought 5,904 Royalty Pharma shares in Q2 2026, an estimated $307K.
- Royalty Pharma made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #940 holding.
- Lido Advisors first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
- 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.